125 related articles for article (PubMed ID: 3359064)
1. [Clinical pharmacokinetics of vinca alkaloids].
Rahmani R; Samak R; Bore P; Cano JP
Bull Cancer; 1988; 75(2):195-200. PubMed ID: 3359064
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of combination effect of navelbine (KW-2307) with cisplatin against human lung adenocarcinoma PC-12 cells in culture.
Gomi K; Ohno H; Nomura K; Okabe M; Kobayashi K; Niitani H
Jpn J Cancer Res; 1992 May; 83(5):532-9. PubMed ID: 1618703
[TBL] [Abstract][Full Text] [Related]
3. [Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
Le Chevalier T; Brisgand D; Pujol JL; Douillard JY; Monnier A; Rivière A; Chomy P; Le Groumellec A; Ruffie P; Gottfried M; Gaspard MH; Chevreau C; Alberola V; Cigolari S; Besson F; Martinez A; Besenval M; Berthaud P; Tursz T
Bull Cancer; 1996 May; 83(5):385-94. PubMed ID: 8680091
[TBL] [Abstract][Full Text] [Related]
4. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
Müller LJ; Moorer-van Delft CM; Zijl R; Roubos EW
Cancer Res; 1990 Mar; 50(6):1924-8. PubMed ID: 2407348
[TBL] [Abstract][Full Text] [Related]
5. Comparative pharmacokinetics of antitumor Vinca alkaloids: intravenous bolus injections of navelbine and related alkaloids to cancer patients and rats.
Rahmani R; Guéritte F; Martin M; Just S; Cano JP; Barbet J
Cancer Chemother Pharmacol; 1986; 16(3):223-8. PubMed ID: 3698163
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and preliminary metabolic fate of navelbine in humans as determined by high performance liquid chromatography.
Jehl F; Quoix E; Leveque D; Pauli G; Breillout F; Krikorian A; Monteil H
Cancer Res; 1991 Apr; 51(8):2073-6. PubMed ID: 1849042
[TBL] [Abstract][Full Text] [Related]
7. Vindesine: a new vinca alkaloid.
Bayssas M; Gouveia J; de Vassal F; Misset JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; Hayat M; Mathé G
Recent Results Cancer Res; 1980; 74():91-7. PubMed ID: 7003662
[TBL] [Abstract][Full Text] [Related]
8. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.
Le Chevalier T; Brisgand D; Douillard JY; Pujol JL; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S
J Clin Oncol; 1994 Feb; 12(2):360-7. PubMed ID: 8113844
[TBL] [Abstract][Full Text] [Related]
9. [Clinical pharmacokinetics of navelbine after oral administration, in vitro metabolism and interindividual variability].
Sahnoun Z; Zhou XJ; Bore P; Monjanel S; Favre R; Durand A; Rahmani R
Bull Cancer; 1990; 77(11):1115-21. PubMed ID: 2275987
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and metabolism of Navelbine.
Krikorian A; Rahmani R; Bromet M; Bore P; Cano JP
Semin Oncol; 1989 Apr; 16(2 Suppl 4):21-5. PubMed ID: 2652317
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics and metabolism of vinca alkaloids.
Rahmani R; Zhou XJ
Cancer Surv; 1993; 17():269-81. PubMed ID: 8137344
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic profile of vinorelbine, a new semi-synthetic vinca alkaloid, determined by high-performance liquid chromatography.
Levêque D; Jehl F; Quoix E; Monteil H
Xenobiotica; 1993 Nov; 23(11):1325-33. PubMed ID: 8310715
[TBL] [Abstract][Full Text] [Related]
13. [A late phase-II trial comparing KW-2307 with vindesine in non-small cell lung cancer (1). Lung cancer section in KW-2307 Study Group].
Furuse K; Yamori S; Negoro S; Fukuoka M; Takada Y; Nakai Y; Ikegami H; Fujii M; Nakajima S; Katakami N
Gan To Kagaku Ryoho; 1995 Jan; 22(1):67-76. PubMed ID: 7826080
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of vincristine, vinblastine, and vindesine in rhesus monkeys.
Sethi VS; Surratt P; Spurr CL
Cancer Chemother Pharmacol; 1984; 12(1):31-5. PubMed ID: 6690071
[TBL] [Abstract][Full Text] [Related]
15. Effective combination therapy of metastatic murine solid tumors with edatrexate and the vinca alkaloids, vinblastine, navelbine and vindesine.
Otter GM; Sirotnak FM
Cancer Chemother Pharmacol; 1994; 33(4):286-90. PubMed ID: 8281620
[TBL] [Abstract][Full Text] [Related]
16. The clinical pharmacokinetics of vinorelbine (Navelbine).
Wargin WA; Lucas VS
Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
[TBL] [Abstract][Full Text] [Related]
17. Human hepatic uptake of two vinca alkaloids: navelbine and vincristine.
Rahmani-Jourdheuil D; Coloma F; Placidi M; Rahmani R
J Pharm Sci; 1994 Apr; 83(4):468-71. PubMed ID: 8046598
[TBL] [Abstract][Full Text] [Related]
18. Uptake of Vinca alkaloids into mammalian nerve and its subcellular components.
Iqbal Z; Ochs S
J Neurochem; 1980 Jan; 34(1):59-68. PubMed ID: 6161213
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of the antitumor drug navelbine (5'-noranhydrovinblastine).
Rahmani R; Bruno R; Iliadis A; Favre R; Just S; Barbet J; Cano JP
Cancer Res; 1987 Nov; 47(21):5796-9. PubMed ID: 3664483
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of vindesine: repeated treatments by intravenous bolus injections.
Rahmani R; Martin M; Favre R; Cano JP; Barbet J
Eur J Cancer Clin Oncol; 1984 Nov; 20(11):1409-17. PubMed ID: 6542010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
